OsteopetrosisPathogenesis and Rationale for the Use of Interferon-γ-1b

被引:0
|
作者
Lakshmi Shankar
Egbert J. A. Gerritsen
L. Lyndon Key
机构
[1] Medical University of South Carolina,Department of Pediatrics and General Clinical Research Center
[2] Hospital for Sick Children NHS Trust and Institute of Child Health,Department of Immunology
来源
BioDrugs | 1997年 / 7卷
关键词
Bone Resorption; Chronic Granulomatous Disease; Osteopetrosis; Osteoclastic Bone Resorption; Dietary Calcium Intake;
D O I
暂无
中图分类号
学科分类号
摘要
Congenital osteopetrosis is a group of disorders resulting in decreased osteoclastic function and hence decreased bone resorption. Various medical treatments have been attempted to ameliorate the osteopetrotic condition. A calcium-deficient diet has limited further sclerosis in some patients. Prednisone therapy has improved haematological function in some patients, but has not resulted in a reduction in bone mass. Calcitrophic hormones, such as parathyroid hormone (PTH) infusions and oral calcitriol, stimulate osteoclastic activity, and calcitriol in particular has stimulated osteoclastic bone resorption in some patients with osteopetrosis. Bone marrow transplantation, although curative, is limited by paucity of donors, risk of graft-versus-host disease and relapse of the disease.
引用
收藏
页码:23 / 29
页数:6
相关论文
共 50 条
  • [1] Interferon-β-1b A Review of its Use in Multiple Sclerosis
    Plosker, Greg L.
    CNS DRUGS, 2011, 25 (01) : 67 - 88
  • [3] Interferon-β1b Treatment in Neuromyelitis Optica
    Tanaka, Masami
    Tanaka, Keiko
    Komori, Mika
    EUROPEAN NEUROLOGY, 2009, 62 (03) : 167 - 170
  • [4] Interferon-β1b for the treatment of multiple sclerosis
    Lam, Sum
    Wang, Shan
    Gottesman, Malcolm
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2008, 4 (08) : 1111 - 1117
  • [5] Interferon-β1b in the treatment of multiple sclerosis
    Río, J
    Montalban, X
    EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (16) : 2877 - 2886
  • [8] Interferon-β-1b -: In newly emerging multiple sclerosis
    McKeage, Kate
    CNS DRUGS, 2008, 22 (09) : 787 - 792
  • [9] Interferon-γ1b for the treatment of idiopathic pulmonary fibrosis
    Bouros, Demosthenes
    Antoniou, Katerina M.
    Tzouvelekis, Argyris
    Siafakas, Nikolaos M.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2006, 6 (10) : 1051 - 1060
  • [10] Treatment of childhood and adolescent MS with interferon-β-1b
    Krupp, L
    Banwell, B
    Boiko, A
    Eraksoy, M
    Freedman, M
    Pohl, D
    Reder, AT
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S245 - S245